株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

感染症向け分子検査市場 (敗血症、呼吸器疾患、HIV、肝炎、結核 (TB) テスト、STI、その他のテスト)

Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)

発行 Kalorama Information 商品コード 911616
出版日 ページ情報 英文 103 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.43円で換算しております。
Back to Top
感染症向け分子検査市場 (敗血症、呼吸器疾患、HIV、肝炎、結核 (TB) テスト、STI、その他のテスト) Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)
出版日: 2019年07月18日 ページ情報: 英文 103 Pages
概要

当レポートでは、世界の感染症向け分子検査市場における市場機会や主要企業の評価を行い、市場の動向、セグメントレベルの詳細な市場規模とその予測を提供しています。。

第1章 エグゼクティブサマリー

第2章 感染症向け分子検査市場における発展

  • 分子POC:新興の競合企業
  • 感染症診断向け分子POC検査の展望
  • STDSのプレゼンスが拡大
  • 新しい真菌感染症が質量分析・シーケンシングにスポットライトを当てる
  • 米国感染症学会 (INFECTIOUS DISEASES SOCIETY OF AMERICA) によるインフルエンザガイドラインのアップデート
  • 菌血症診断のためのPCRベースアッセイが研究中の血液培養に先んじる
  • MeridianがGenePOCを買収
  • T2Bacteria 研究は近年の研究で価値を示す、ほか

第3章 感染症向け分子診断市場

  • 世界市場の分析
  • CT/NG、HPVおよび女性の健康
  • 肝炎
  • HIV
  • HAI (医療関連感染)
  • 呼吸器疾患
  • マイコバクテリア/結核

第4章 企業プロファイル

  • ABBOTT DIAGNOSTICS
  • BECTON, DICKINSON & CO. (BD)
  • BIO-RAD LABORATORIES
  • DANAHER (CEPHEID AND LEICA BIOSYSTEMS)
  • MERIDIAN BIOSCIENCE INC
  • QIAGEN N.V.
  • QUIDEL CORPORATION
  • ROCHE DIAGNOSTICS
目次
Product Code: 19-046

Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts.

Test Segments: Market Sizing and Forecasts

There are several segments where testing at the molecular level has thrived, including the following:

  • HPV Testing
  • CT/NG Testing
  • Molecular Hepatitis Testing
  • HIV Testing
  • Hospital Acquired Infections and Sepsis Testing
  • Respiratory Diseases Testing
  • Mycobacteria/Tuberculosis Testing

The report does not contain information on blood banking, blood typing or NAT screen tests. These are covered in Kalorama Information's ‘The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition’.

Regional Distribution

For each of these segments, the report provides a breakout for the following regions:

  • North America
  • Europe
  • Asia Pacific
  • Other

Company Profiles

Companies covered in this report include:

  • Abbott
  • bioMérieux
  • Bio-Rad
  • Cepheid
  • Meridian
  • Qiagen
  • Quidel
  • Roche

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • THE GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET
    • Figure 1-1 Molecular Infectious Disease Market, 2019-2014
  • TEST SEGMENTS
  • EMERGING TRENDS INFLUENCING THE MARKET LANDSCAPE

CHAPTER TWO: DEVELOPMENTS IN MOLECULAR INFECTIOUS DISEASE TESTING

  • MOLECULAR POC: UPSTART COMPETITORS
  • PROSPECTS FOR MOLECULAR POC TESTING FOR INFECTIOUS DISEASES DIAGNOSTICS
    • Table 2-1: Selected Molecular POC Platforms in the Market for Infectious Disease Testing
  • INCREASED PRESENCE OF STDS
  • LYME DISEASE: MAJOR IVD LEAPS IN WITH MOLECULAR SOLUTIONS
  • NEW FUNGAL INFECTION SPOTLIGHTS MASS SPEC AND SEQUENCING
  • UPDATED INFLUENZA GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA
  • PCR-BASED ASSAY FOR DIAGNOSIS OF BACTEREMIA BEATS BLOOD CULTURES IN STUDY
  • MERIDIAN ACQUIRES GENEPOC
  • T2BACTERIA STUDY DEMONSTRATES WORTH IN RECENT STUDY
  • BRUKER COMPLETES ACQUISITION OF MAJORITY INTEREST IN INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS COMPANY HAIN LIFESCIENCE GMBH
  • REIMBURSEMENT ENVIRONMENT FOR MOLECULAR DIAGNOSTICS
  • NEW PROJECT USES SEQUENCING FOR TB DIAGNOSIS IN EMERGING NATIONS
  • GROWING MICROHOSPITAL BUSINESS BECKONS CLINICAL LABS
  • NEW EIGHT BACTERIA GRAM-NEGATIVE TEST CLEARED BY FDA
  • CLINICAL UTILITY OF MOLECULAR DIAGNOSTICS
  • AI ASSISTING WITH MOLECULAR COLORECTAL DIAGNOSIS

CHAPTER THREE: MARKETS FOR MOLECULAR INFECTIOUS DISEASE DIAGNOSTICS

  • Table 3-1: Selected Integrated Clinical Molecular Systems in the Market for Infectious Disease Diagnostics
  • MARKET ANALYSIS - GLOBAL
    • Table 3-2: Market by Segments (%) (HIV and Hepatitis, Hospital, STIs and HPV, Other)
    • Table 3-3: Global Molecular Infectious Disease Diagnostics Markets (2019-2024), by Infection ($, Million) (Hepatitis, HIV, HAIs/Sepsis, HPV, CT/NG, Respiratory Diseases, Mycobacteria/TB, Other, Total)
    • Table 3-4: Global Molecular Infectious Disease Diagnostics Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • CT/NG, HPV and Women's Health
    • Table 3-5: Global Molecular HPV Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
    • Table 3-6: Global Molecular CT/NG Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Hepatitis
    • Table 3-7: Global Molecular Hepatitis Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • HIV
    • Table 3-8: Innovations in Molecular POC Diagnostics for HIV
    • Table 3-9: Global Molecular HIV Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Hospital-Acquired Infections (HAIs)
    • Table 3-10: Global Molecular HAIs/Sepsis Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Respiratory Diseases
    • Table 3-11: Global Molecular Respiratory Diseases Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Mycobacteria/Tuberculosis
    • Table 3-12: Global Molecular Mycobacteria/TB Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)

CHAPTER FOUR: COMPANY PROFILES

  • ABBOTT DIAGNOSTICS
  • The Molecular Diagnostics Business Post-Acquisition of Alere
  • BECTON, DICKINSON & CO. (BD)
  • Business Segments
  • Molecular Diagnostics Focus
  • BIOM
  • Molecular
  • BIO-RAD LABORATORIES
  • DANAHER (CEPHEID AND LEICA BIOSYSTEMS)
  • Life Sciences Business
  • Diagnostics Business
  • Cepheid
  • Leica Biosystems
  • Danaher's 2018 Performance and 2019 Expectations
  • Acquisitions and Divestments in 2018 / 2019
  • MERIDIAN BIOSCIENCE INC
  • QIAGEN N.V.
  • Consumables and Related Revenues
  • Automation Platform and Instrumentation
  • Molecular Diagnostics Applications
  • Applied Testing
  • Pharma and Academia
  • New Developments (in 2018 until mid-2019)
  • Developments in Automation Systems
  • Bioinformatics Solutions
  • QUIDEL CORPORATION
  • ROCHE DIAGNOSTICS
  • Global Access Program for HIV
  • Core Molecular
  • cobas Liat System - POC
  • Partnering with Information Technology
  • Product Launches in 2018
Back to Top